Baylor College of Medicine

What Baylor College of Medicine does

Baylor College of Medicine (BCM) is a private, nonprofit academic medical institution founded in 1900 and headquartered at 1 Baylor Plaza within the Texas Medical Center in Houston, Texas. It operates four schools — the School of Medicine, Graduate School of Biomedical Sciences, National School of Tropical Medicine, and School of Health Professions — together with a clinical practice (Baylor Medicine), a research enterprise of 1,500+ faculty, and wholly owned subsidiary Baylor Genetics. Its revenue is generated from four streams: tuition and fees from degree and training programs, federal and state research grants (NIH, NSF, CPRIT, ARPA-H), clinical care delivered through affiliated hospitals (Texas Children's Hospital, Baylor St. Luke's Medical Center, Harris Health System, and Michael E. DeBakey VA Medical Center), and philanthropy and endowed chairs.

The institution's core technology footprint spans advanced biomedical research infrastructure, including genomic sequencing, proteomics (notably as an early-access customer for Nautilus' Voyager platform), cryo-electron microscopy, single-cell genomics, and computational biology. Proprietary research outputs include MAR-T cell therapy for pancreatic cancer (licensed to Marker Therapeutics), DOC1021 dendritic cell therapy (licensed to Diakonos Oncology), YAP101 cardiac gene therapy (licensed to Medley Therapeutics), and the GP2 HER2-positive breast cancer immunotherapy. BCM participates in major consortia including BrainGate (brain-computer interfaces with Rice University), MICrONS (1.6 petabyte brain connectomics dataset), TexWEB (HIV wastewater surveillance across 2,000+ samples in 15 Texas cities), and the ARPA-H DATAMAP project for AI drug toxicity prediction.

BCM is led by President and CEO Dr. Paul Klotman, who retires in June 2026, with Dr. Jakub Tolar identified as successor. Strategic posture in 2025–2026 has emphasized expansion into AI-driven drug discovery (Inductive Bio, Site Tx, Oracle), brain-computer interface clinical trials (BrainGate, Motif Neurotech), and commercial proteomics and sequencing partnerships (Nautilus, Illumina), alongside traditional academic revenue streams.

Name

Baylor College of Medicine

Legal name

Baylor College of Medicine

Website

https://bcm.edu

Company type

Private

Founded year

1900

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Baylor College of Medicine is a private academic medical center in Houston's Texas Medical Center operating four schools (Medicine, Biomedical Sciences, Tropical Medicine, Health Professions), a clinical practice, and a research enterprise of 1,500+ faculty. It serves patients, students, and research partners across the U.S. and globally.

Ownership category

akta.pro rank

Product category

Academic Medical Center

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Research and Development in Biotechnology (except Nanobiotechnology) (541714), General Medical and Surgical Hospitals (62211)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Medical education
• Biomedical research
• Clinical care services
• Academic medical center
• Health professions training

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical and Health Professions Education: Tuition and fees from MD, PhD, and health professions degree programs including the School of Medicine, Graduate School of Biomedical Sciences, National School of Tropical Medicine, and School of Health Professions
2. Research Grants and Sponsored Programs: Federal and state research funding from NIH, NSF, CPRIT, and other agencies supporting biomedical research across all departments and research centers
3. Clinical Care Revenue: Patient care services through Baylor Medicine practice plan providing specialized medical services across all specialties
4. Philanthropy and Endowments: Charitable contributions, endowed chairs, and research funding from private donors and foundations

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Baylor College of Medicine is a private health sciences university delivering medical education (MD, PhD, and health professions degrees across four schools), advanced biomedical and translational research funded primarily through NIH and other grants, and specialized patient care through its Baylor Medicine clinical practice and affiliated hospitals in the Texas Medical Center. The institution integrates teaching, research, and clinical service to train physicians and scientists, advance scientific knowledge, and provide specialty medical care.

Product overview

Baylor College of Medicine is an academic medical institution providing healthcare services through its clinical practice Baylor Medicine, educational programs across four schools (School of Medicine, Graduate School of Biomedical Sciences, National School of Tropical Medicine, School of Health Professions), and research conducted through numerous departments and research centers. The institution does not offer commercial software products or SaaS offerings; its services consist of patient care, medical education, and scientific research.

Differentiator

Problem solved

Functional benefit

Brands

• Baylor Medicine: The clinical practice of Baylor College of Medicine, delivering compassionate, innovative, evidence-based care as Houston's premier academic medical practice.
• Baylor St. Luke's Medical Center
• Texas Children's Hospital

Products and services

• M.D. Program

Quantifiable outcome

• 84.6% disease control rate in pancreatic cancer patients with Multi-Antigen Targeted T cells (Nature Medicine Phase 1/2 trial)
• +5 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature12 records

Partnerships

16 partnerships are on record, tiered core, minor and flagship.

• Rice UniversitycoreStrategic or Co-development Partner · 28 May 2026Rice University and BCM joined the BrainGate consortium as the first Texas-based team to advance brain-computer interface technologies for people with paralysis. BCM leads clinical activities including neurosurgical implantation and participant recruitment for the BrainGate2 clinical trial, while Rice develops algorithms to decode cortical neural signals for controlling robotic assistive devices.
• Coreline SoftminorStrategic or Co-development Partner · 30 April 2026BCM is among clinical partners for Coreline Soft's AVIEW CAC AI imaging product that received new HCPCS billing code G0680 for AI-based coronary artery calcification detection from chest CT scans.
• Motif NeurotechcoreStrategic or Co-development Partner · 28 April 2026BCM is one of up to eight medical institutions participating in Motif Neurotech's RESONATE trial for the DOT brain implant for treatment-resistant depression. The FDA-cleared trial tests the blueberry-sized device that delivers targeted electrical stimulation.
• Texas Children's Duncan Neurological Research InstitutecoreStrategic or Co-development Partner · 23 April 2026Dr. Damian Young and collaborators at the Duncan Neurological Research Institute awarded $6.7 million NIH grant for Alzheimer's drug discovery using DNA-encoded chemical libraries and AI to screen hundreds of millions of compounds.
• University of HoustoncoreStrategic or Co-development Partner · 24 March 2026BCM is a partner in University of Houston's $11.8 million NIH-funded study on early language development in toddlers. The study establishes a Clinical Research Center on Developmental Language Disorders with BCM and Texas Children's contributing expertise.
• Nautilus BiotechnologycoreTechnology or Integration · 18 March 2026BCM is the first customer of Nautilus' Iterative Mapping Early Access Program for the Voyager proteomics platform. NIH-funded BCM researchers will use the platform to develop computational toolkit for identifying aberrant protein isoforms in cancer research, mapping up to 10 billion intact proteins per run.
• Colossal BiosciencesminorStrategic or Co-development Partner · 12 March 2026Partnership with Colossal Biosciences and Houston Zoo to develop mRNA vaccine for elephant endotheliotropic herpesvirus. BCM contributed to vaccine development that successfully saved two vaccinated young elephants at Cincinnati Zoo.
• University of North Carolina (UNC) Structural Genomics ConsortiumminorStrategic or Co-development Partner · 25 February 2026BCM researchers participate in Gates Foundation-funded open science initiative for nonhormonal contraceptive development targeting sperm-specific enzyme PGK2. Collaboration involves researchers from UNC, BCM, and Institute for Stem Cell Science in Bangalore, India.
• AstraZeneca Centre for Genomics ResearchminorStrategic or Co-development Partner · 28 January 2026BCM collaborated with AstraZeneca's Centre for Genomics Research and Memorial Sloan Kettering on largest-ever EBV study analyzing 750,000 people, identifying 22 genetic variants linked to chronic diseases including autoimmune conditions and cancers.
• Marker TherapeuticsflagshipOEM/ Whitelabel/ Licensing Partner · 5 January 2026BCM published promising MAR-T cell therapy results for pancreatic cancer (84.6% disease control rate). Marker Therapeutics holds worldwide exclusive license for this technology and plans to initiate its own Phase 1 pancreatic cancer clinical trial in H1 2026.
• Inductive BioflagshipStrategic or Co-development Partner · 10 December 2025BCM participates in the DATAMAP project led by Inductive Bio, awarded up to $21 million from ARPA-H. The project develops AI drug toxicity prediction models using human-based systems for drug-induced liver injury and cardiotoxicity. BCM contributes human model systems expertise alongside Amgen, Cincinnati Children's, and Torch Bio.
• Feinstein Institutes for Medical ResearchminorStrategic or Co-development Partner · 23 October 2025BCM collaborates with Feinstein Institutes on $3.2 million NIH-funded research on polygenic embryo selection (PES) technology, assessing scientific accuracy and ethical implications of evaluating embryos for disease risks during IVF.
• Oracle Health and Life SciencescoreStrategic or Co-development Partner · 21 October 2025Collaboration to advance research into alcohol-related liver disease (ALD) using Oracle's AI data platform and real-world data. BCM will leverage Oracle's platform containing over 120 million patient records to establish a cohort of over one million ALD patients.
• Spark BiomedicalminorStrategic or Co-development Partner · 20 October 2025BCM partnered with Spark Biomedical and Menninger Clinic for $305,000 NIH-funded study of transcutaneous auricular neurostimulation (tAN) technology for treating alcohol withdrawal symptoms.
• Site Tx, Inc.coreStrategic or Co-development Partner · 4 September 2025Multi-year collaboration to develop novel small-molecule drugs for immune regulation. Combines BCM's DNA-encoded library of over 7 billion unique compounds with Site Tx's functional genomics platform for drug candidate identification.
• Multiple Texas Institutions (TexWEB Initiative)coreStrategic or Co-development PartnerTexas Wastewater and Environmental Biomonitoring (TexWEB) initiative involving multiple institutions to detect HIV-1 in community wastewater using hybrid-capture genetic sequencing. The method was validated across over 2,000 samples from 40 sites in 15 Texas cities.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Others

• Washington University School of Medicine in St. Louis:

Direct peers

• Johns Hopkins University School of Medicine: Top-tier private research medical school with an integrated academic medical center, NIH funding leadership, and a similar tripartite mission of education, research, and clinical care — the closest benchmark for BCM.
• Harvard Medical School: Elite private medical school with deep NIH funding, affiliated teaching hospitals, and major biotech/pharma industry partnerships — comparable to BCM in research intensity and pipeline scope.
• University of Pennsylvania Perelman School of Medicine: Top-10 private research medical school with an integrated AMC, strong NIH funding, CAR-T cell therapy development, and similar commercialization infrastructure via the Penn Center for Innovation.
• Stanford University School of Medicine: Private research medical school with deep NIH funding, biotech ecosystem integration, and AI/biomedical research initiatives comparable in scale and ambition to BCM's AI drug-discovery partnerships.
• University of Texas Southwestern Medical Center: Texas-based peer academic medical center with strong NIH funding, biomedical research strength, and overlapping CPRIT funding pool — the most direct Texas competitor for faculty, trainees, and grants.
• Duke University School of Medicine: Private research medical school with integrated Duke University Health System, strong translational research output, and comparable scale of clinical trials and licensing activity.
• Weill Cornell Medicine: Private research medical school in New York with affiliated hospital network (NewYork-Presbyterian), NIH funding leadership, and a comparable specialty-research and graduate-training portfolio.
• Columbia University Vagelos College of Physicians and Surgeons: Elite private medical school affiliated with NewYork-Presbyterian, comparable research funding scale, and similar emphasis on biomedical discovery and physician-scientist training.
• UCSF School of Medicine: Leading public medical school with the highest NIH funding in the country, an integrated academic health system, and a comparable translational-research and clinical-trials footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bcmhouston
• YouTubeyoutube.com/user/BCMweb
• Facebookfacebook.com/BaylorCollegeOfMedicine
• LinkedInlinkedin.com/company/baylor-college-of-medicine
• Instagraminstagram.com/bcmhouston

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Baylor College of Medicine